Evidence map

ArticleCardiovascular diabetology2023

Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes.

Damien Denimal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 37143040